• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期III期乳腺癌的动脉内诱导化疗。

Intraarterial induction chemotherapy in locally advanced stage III breast cancer.

作者信息

Stephens F O

机构信息

Department of Surgery, University of Sydney, NSW, Australia.

出版信息

Cancer. 1990 Aug 15;66(4):645-50. doi: 10.1002/1097-0142(19900815)66:4<645::aid-cncr2820660407>3.0.co;2-w.

DOI:10.1002/1097-0142(19900815)66:4<645::aid-cncr2820660407>3.0.co;2-w
PMID:2386893
Abstract

Five-year results are reported on 27 patients with locally advanced breast cancer treated by intraarterial induction chemotherapy followed by radiotherapy and/or surgery with subsequent adjuvant chemotherapy. The cyclic infusion chemotherapy regimen was given over 3 to 6 weeks using Adriamycin (doxorubicin), 5-fluorouracil (5-FU), vincristine, and methotrexate in daily rotation. Regional and systemic side effects were minimal and temporary except in two patients in whom some skin discoloration has remained. Local tumor control and 5-year cures depended on two important factors: whether follow-up mastectomy was used after initial local tumor regression; and whether the carcinoma was classified as "inflammatory" with pathologic evidence of tumor invasion of dermal lymphatics. Of 16 patients with noninflammatory carcinoma treated by chemotherapy, radiotherapy, and mastectomy local tumor eradication was achieved in 15 and 5-year apparent cure in 11. Of six patients with noninflammatory carcinoma treated with chemotherapy and radiotherapy but no mastectomy 5-year local control was achieved in only three and 5-year apparent cure in three. Of five patients with pathologic inflammatory carcinoma local tumor control was achieved in only one and only this one patient has been a 5-year survivor apparently tumor-free.

摘要

报告了27例局部晚期乳腺癌患者的五年结果,这些患者接受了动脉内诱导化疗,随后进行放疗和/或手术,并进行辅助化疗。采用阿霉素(多柔比星)、5-氟尿嘧啶(5-FU)、长春新碱和甲氨蝶呤每日轮流给药,在3至6周内进行循环灌注化疗。除两名患者仍有一些皮肤变色外,局部和全身副作用轻微且为暂时性。局部肿瘤控制和五年治愈率取决于两个重要因素:初始局部肿瘤消退后是否进行后续乳房切除术;以及癌症是否被归类为“炎性”,并有肿瘤侵犯真皮淋巴管的病理证据。在16例接受化疗、放疗和乳房切除术的非炎性癌患者中,15例实现了局部肿瘤根除,11例实现了五年表观治愈。在6例接受化疗和放疗但未进行乳房切除术的非炎性癌患者中,只有3例实现了五年局部控制,3例实现了五年表观治愈。在5例病理炎性癌患者中,只有1例实现了局部肿瘤控制,只有这名患者成为了五年幸存者,显然无肿瘤。

相似文献

1
Intraarterial induction chemotherapy in locally advanced stage III breast cancer.局部晚期III期乳腺癌的动脉内诱导化疗。
Cancer. 1990 Aug 15;66(4):645-50. doi: 10.1002/1097-0142(19900815)66:4<645::aid-cncr2820660407>3.0.co;2-w.
2
Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer.
Breast Cancer Res Treat. 1993 Dec;28(3):277-84. doi: 10.1007/BF00666589.
3
Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.局部晚期乳腺癌诱导化疗的病理反应:预后的决定因素。
J Am Coll Surg. 1995 Mar;180(3):297-306.
4
Management of inflammatory carcinoma of the breast with combined modality therapy including intraarterial infusion chemotherapy as an induction therapy. Long-term follow-up results of 28 patients.采用包括动脉内灌注化疗作为诱导治疗的综合治疗方法对炎性乳腺癌进行管理。28例患者的长期随访结果
Cancer. 1988 Apr 15;61(8):1483-91. doi: 10.1002/1097-0142(19880415)61:8<1483::aid-cncr2820610802>3.0.co;2-2.
5
Intra-arterial infusion chemotherapy in the treatment of locally advanced breast cancer.动脉内灌注化疗治疗局部晚期乳腺癌。
Acta Oncol. 1997;36(5):489-92. doi: 10.3109/02841869709001304.
6
Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.
Cancer. 1988 Dec 15;62(12):2507-16. doi: 10.1002/1097-0142(19881215)62:12<2507::aid-cncr2820621210>3.0.co;2-d.
7
Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.米托蒽醌、丝裂霉素-C、甲氨蝶呤联合化疗并结合放疗和/或手术治疗Ⅲ期(T4B,NO-2,M0)乳腺癌。
J Assoc Physicians India. 1998 Nov;46(11):926-9.
8
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.高危乳腺癌患者接受16周剂量密集辅助化疗后的长期随访
Cancer. 1999 Feb 15;85(4):899-904.
9
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.局部晚期乳腺癌伴同侧锁骨上转移联合治疗的长期结果:德克萨斯大学MD安德森癌症中心的经验。
J Clin Oncol. 2001 Feb 1;19(3):628-33. doi: 10.1200/JCO.2001.19.3.628.
10
Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.局部晚期乳腺癌新辅助治疗的长期结果:有效的临床降期可实现保乳,并预示着出色的局部控制和生存情况。
Ann Surg. 2002 Sep;236(3):295-302; discussion 302-3. doi: 10.1097/01.SLA.0000027526.67560.64.

引用本文的文献

1
Clinical efficacy and value of redistributed subclavian arterial infusion chemotherapy for locally advanced breast cancer.局部晚期乳腺癌再分配锁骨下动脉灌注化疗的临床疗效及价值。
Jpn J Radiol. 2011 May;29(4):236-43. doi: 10.1007/s11604-010-0547-5. Epub 2011 May 24.
2
Intra-arterial chemotherapy in patients with breast cancer: a feasibility study.乳腺癌患者的动脉内化疗:一项可行性研究。
Br J Cancer. 1995 Mar;71(3):605-9. doi: 10.1038/bjc.1995.117.
3
The management of locally advanced breast cancer.局部晚期乳腺癌的管理
Br J Cancer. 1992 Feb;65(2):145-7. doi: 10.1038/bjc.1992.31.